Sponsor pipeline

Humacyte, Inc. clinical trial pipeline

Get alerts when Humacyte, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1
Phase 3
2
Phase 4
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07762794 Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting… Vascular Injury Not Yet Recruiting 2026-08-13
Phase 3
NCT07762313 An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit… Vascular Trauma Not Yet Recruiting 2026-08-13
NCT05908084 To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage… End Stage Renal Disease (ESRD) Active, Not Recruiting 2026-06-26
Phase 2
NCT07730528 Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel… Coronary Artery Disease Not Yet Recruiting 2026-07-28

Disease areas by active trials

Get alerts when Humacyte, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free